NewEdge Advisors’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.12M Buy
39,213
+30,151
+333% +$957K ﹤0.01% 1588
2026
Q1
$285K Buy
9,062
+8,306
+1,099% +$262K ﹤0.01% 2374
2025
Q4
$22.3K Hold
756
– – ﹤0.01% 3224
2025
Q3
$19.1K Hold
756
– – ﹤0.01% 3140
2025
Q2
$18.1K Hold
756
– – ﹤0.01% 2990
2025
Q1
$17.3K Hold
756
– – ﹤0.01% 2912
2024
Q4
$19.1K Hold
756
– – ﹤0.01% 2818
2024
Q3
$18.8K Hold
756
– – ﹤0.01% 2734
2024
Q2
$22.4K Buy
756
+420
+125% +$11.7K ﹤0.01% 2592
2024
Q1
$10.1K Sell
336
-1,979
-85% -$54.9K ﹤0.01% 2877
2023
Q4
$66.2K Buy
2,315
+794
+52% +$23.3K ﹤0.01% 2116
2023
Q3
$56.4K Buy
1,521
+61
+4% +$2.33K ﹤0.01% 2060
2023
Q2
$57K Buy
1,460
+1,020
+232% +$40K ﹤0.01% 2048
2023
Q1
$16.1K Sell
440
-1,315
-75% -$41.5K ﹤0.01% 2414
2022
Q4
$12.2K Buy
+1,755
New +$54.5K ﹤0.01% 2307

Other funds holding RTO

NewEdge Advisors's RTO Position: Q2 2026 in Review

NewEdge Advisors increased its Rentokil (RTO) stake by 333% in Q2 2026, buying an estimated $957K and bringing the position to 39,213 shares worth $1.12M. The position accounts for ﹤0.01% of the portfolio, ranked #1588.

NewEdge Advisors first reported a position in RTO in Q4 2022 and has held it in 15 quarters since. 284 funds tracked by Wall St. Rank hold RTO as of Q2 2026.

  • NewEdge Advisors held 39,213 shares of Rentokil worth $1.12M as of Q2 2026.
  • NewEdge Advisors bought 30,151 Rentokil shares in Q2 2026, an estimated $957K.
  • Rentokil made up ﹤0.01% of NewEdge Advisors's portfolio in Q2 2026, its #1588 holding.
  • NewEdge Advisors first reported a position in Rentokil in Q4 2022 and has held it in 15 quarters since.
  • 284 funds tracked by Wall St. Rank held Rentokil as of Q2 2026.

Based on NewEdge Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.